Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 1—January 2011

Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009

Frederick N. BaliraineComments to Author , Josephine Bwogi, Henry Bukenya, Ronald Seguya, Theopista Kabaliisa, Annet Kisakye, William B. Mbabazi, and Sheilagh B. Smit
Author affiliations: Author affiliations: University of California, San Francisco, California, USA (F.N. Baliraine); Uganda Virus Research Institute, Entebbe, Uganda (J. Bwogi, H. Bukenya, R. Seguya, T. Kabaliisa); Uganda National Expanded Program for Immunization, Entebbe (A. Kisakye); World Health Organization, Kampala, Uganda (A. Kisakye); Management Sciences for Health/Strengthening Pharmaceutical Systems, Juba, Sudan (W.B. Mbabazi); National Institute for Communicable Diseases, Johannesburg, South Africa (S.B. Smit)

Main Article


Epidemiologic data associated with measles virus isolates analyzed, Uganda, 2006‒2009*

Isolate name District Patient age, mo Measles vaccine doses Vaccination card seen Date of onset Interval, d† Measles IgM GenBank accession no. Identity‡
MVi/Bushenyi.UGA/43.06 Bushenyi 19 1 No 2006 Oct 4 Pos GU952229 A
MVi/Hoima.UGA/7.09/1 Hoima 36 X No 2009 Feb 5 Pos GU952246 B
MVi/Hoima.UGA/7.09/2 Hoima 36 X No 2009 Feb 2 Neg B
MVi/Kampala.UGA/26.06/1 Kampala 30 X No 2006 Jun 1 Pos GU952239 A
MVi/Kampala.UGA/26.06/2 Kampala 36 X No 2006 Jun 4 Pos A
MVi/Kampala.UGA/26.06/3 Kampala 18 0 No 2006 Jun 2 ND GU952237 C
MVi/Kasese.UGA/7.07/1 Kasese 25 0 Yes 2007 Feb 2 Pos GU952245 A
MVi/Kasese.UGA/7.07/2 Kasese 240 X No 2007 Feb 3 Pos A
MVi/Kitgum.UGA/28.06 Kitgum 60 2 No 2006 Jul 3 Pos GU952235 A
MVi/Mukono.UGA/26.06 Mukono 96 0 No 2006 Jun 1 Pos GU952238 D
MVi/Mukono.UGA/29.06 Mukono 276 X No 2006 Jul 3 Pos GU952233 E
MVi/Mukono.UGA/47.06 Mukono 48 1 Yes 2006 Nov 1 Pos GU952243 F
MVi/Wakiso.UGA/26.06 Wakiso 36 2 No 2006 Jun 1 Pos GU952240 A
MVi/Wakiso.UGA/27.06 Wakiso 96 0 No 2006 Jul 1 Pos GU952236 C
MVi/Wakiso.UGA/29.06 Wakiso 33 0 Yes 2006 Jul 1 Pos GU952234 A
MVi/Wakiso.UGA/31.06/1 Wakiso 19 1 No 2006 Jul 1 Pos GU952232 G
MVi/Wakiso.UGA/31.06/2 Wakiso 25 0 No 2006 Aug 2 Pos GU952231 A
MVi/Wakiso.UGA/32.06 Wakiso 11 X No 2006 Aug 1 Pos GU952230 A
MVi/Wakiso.UGA/41.06 Wakiso 27 0 No 2006 Oct 1 Pos GU952241 A
MVi/Wakiso.UGA/45.06 Wakiso 120 2 No 2006 Nov 2 Pos GU952242 H
MVi/Wakiso.UGA/49.06 Wakiso 216 1 No 2006 Dec 2 Pos GU952244 A

*All were genotype B3.1. IgM, immunoglobulin M; pos, positive; neg, negative; X, unknown; ND, not done.
†Time between rash onset and sample collection.
‡Nucleotide sequences sharing the same letter are identical.

Main Article

Page created: July 18, 2011
Page updated: July 18, 2011
Page reviewed: July 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.